Rating
Buy
Price target
$229
Previous
$229
Implied upside
+53%

Cantor Fitzgerald analyst Thomas Blakey reiterated an Overweight rating and $229.00 price target on Oracle (NYSE: ORCL).

“Oracle delivered strong AI-driven momentum in F3Q26, with robust growth in AI infrastructure (+243%) and multicloud DBaaS revenue (+531%) alongside solid SaaS performance (+13% reported, +11% cc), which was explained as being possibly immune to the SaaS-pocalypse.

Management highlighted halo effects from AI infrastructure and sovereign cloud, driving broader enterprise engagement with its end-to-end solution set, better positioning the company versus SaaS-only app providers.

Given its diverse product set, Oracle appears to be taking a more disruptive approach to deploying AI agents across its applications and application suites, as well as aggressively utilizing coding tools internally to use smaller, more agile teams to deliver SaaS enhancements more quickly to customers, leveraging its data gravity associated with its AI platform and core DB services.

AI infrastructure margins exceeded expectations at 32%, supporting confidence in long-term profitability as scale improves in this important business line and core IaaS/OCI (excl CDBS) is now approaching 25% of total revenue and growing ~100% y/y, by our estimation.

We see Oracle’s vertically integrated stack (OCI, AI data platform, and applications) positioning the company to capture outsized AI-driven demand across its ecosystem of apps, DB, and infrastructure services, and driving sustainable profitable growth supporting our OW rating and our $229 PT.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.